The present invention relates to compounds of formula I ##STR00001## and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors.

 
Web www.patentalert.com

< Modified release formulations of a bupropion salt

> Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase

> Gastro-electric stimulation for reducing the acidity of gastric secretions or reducing the amounts thereof
~ 00534